Should You Sell Your Stake in Nu Skin Enterprises (NUS)?
Aristotle Capital Boston's Small Cap Equity Fund liquidated its position in Nu Skin Enterprises (NYSE: NUS) due to deteriorated fundamental performance and an uncertain strategic transformation outlook. Despite its strong past twelve-month performance, the company saw a significant one-month decline. The article highlights that Nu Skin is not among the 30 most popular stocks among hedge funds, suggesting that AI stocks might offer greater return potential.
Short Interest in Nu Skin Enterprises, Inc. (NYSE:NUS) Drops By 16.0%
Nu Skin Enterprises (NYSE:NUS) experienced a 16.0% decrease in short interest in January, totaling 1,758,724 shares as of January 30th. This represents about 3.7% of shares outstanding with a days-to-cover ratio of 3.0 days. The company recently missed Q4 earnings estimates, but declared a quarterly dividend of $0.06 and is largely held by institutional investors with a "Hold" consensus rating from analysts.
Nu Skin Enterprises, Inc. (NYSE:NUS) Q4 2025 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NYSE: NUS) reported its Q4 2025 earnings, with EPS slightly missing expectations but showing a strong 51% growth year-over-year. The company is undergoing a strategic transformation, centered on the launch of Prism IO, an intelligent wellness platform, and expansion into emerging markets like India. Nu Skin anticipates returning to growth by late 2026, driven by these initiatives and continued operational efficiency improvements.
$1 EPS outlook and India launch: inside Nu Skin’s 2026 plan
Nu Skin Enterprises (NYSE: NUS) reported Q4 2025 revenue of $370.3M and adjusted EPS of $0.29, which was at the high end of their guidance despite missing Stonegate Capital's revenue estimates. The company highlighted robust gross margins, disciplined spending, and strategic expansion into India, with a full launch expected in the second half of 2026. Nu Skin projects a FY26 EPS midpoint of $1.00 as it focuses on its Prysm iO rollout and geographic growth initiatives.
$0.06-a-share payout: Nu Skin sets March 11 dividend for investors
Nu Skin Enterprises, Inc. (NYSE: NUS) has announced a quarterly cash dividend of $0.06 per share. This dividend will be paid on March 11, 2026, to shareholders of record as of February 27, 2026. The company, an intelligent beauty and wellness platform, operates in nearly 50 global markets.
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
Nu Skin Enterprises reported fourth quarter and full-year 2025 results that met revenue and earnings guidance, with over 50% growth in earnings for the full year 2025. The company is strategically focusing on the global launch of Prysm iO, an intelligent wellness device, and expanding into India to drive year-over-year revenue growth by the end of 2026. Nu Skin provided an initial outlook for Q1 and fiscal year 2026, projecting continued investment in growth initiatives.
Nu Skin Enterprises Q4 Earnings, Revenue Decline
Nu Skin Enterprises reported a decline in its Q4 earnings and revenue. The company also announced its Q4 2025 earnings call for February 12, 2026, and provided future earnings guidance for the full year 2025. Nu Skin develops and distributes beauty and wellness solutions globally across various segments.
Nu Skin Enterprises (NYSE:NUS) Share Price Passes Above 200 Day Moving Average - Here's What Happened
Nu Skin Enterprises (NYSE:NUS) saw its share price move above its 200-day moving average to $10.6120, even as analyst sentiment has shifted to "Reduce." The company reported beating quarterly EPS estimates ($0.34 vs. $0.30) but missed revenue expectations and has a market cap of approximately $517.3 million. Nu Skin also announced a quarterly dividend of $0.06 and provided FY2025 EPS guidance between $1.25 and $1.35.
Nu Skin Enterprises to Announce Fourth Quarter and Full Year 2025 Financial Results
Nu Skin Enterprises (NYSE: NUS) will release its fourth quarter and full year 2025 financial results after the market closes on Thursday, February 12, 2026. The management team will host a conference call on the same day at 5 p.m. ET to discuss the results and upcoming business initiatives. A webcast of the conference call and financial information will be available on the company’s investor relations website, with a replay available until February 26.
Nu Skin Enterprises to Announce Fourth Quarter and Full Year 2025 Financial Results
Nu Skin Enterprises Inc. (NYSE: NUS) will release its fourth quarter and full year 2025 financial results after the market closes on Thursday, February 12th. Following the release, the management team will host a conference call at 5 p.m. ET to discuss the results and upcoming business initiatives. A webcast of the call and financial information will be available on the company's investor relations page, with a replay accessible until February 26th.
BWMX: 2026 Signposts: Returns Set to Continue Upward Path; Reiterate Buy, PT
Small Cap Consumer Research LLC reiterates a Buy rating and $22.50 price target for Betterware de Mexico (BWMX), citing expected top-line growth for both the Betterware division and JAFRA Mexico in 2026, following a period of inventory reduction and return optimization in 2025. The firm believes BWMX remains a compelling investment due to anticipated expansion into new countries, strong financial discipline, continued balance sheet deleveraging, and an attractive dividend yield of approximately 7.3%.
Pacer Advisors Inc. Lowers Holdings in Nu Skin Enterprises, Inc. $NUS
Pacer Advisors Inc. significantly reduced its stake in Nu Skin Enterprises (NYSE:NUS) by 55.1% in Q3, selling 267,419 shares. Despite this, other institutional investors like Prescott Group Capital Management and Prudential Financial Inc. increased their positions, with institutional ownership now at 82.84%. Nu Skin reported Q3 EPS of $0.34, exceeding estimates, with a market capitalization of $472.7 million and a price-to-earnings ratio of 4.45.
Nu Skin (NUS) details 2024 social impact, sustainability gains | NUS Stock News
Nu Skin Enterprises, Inc. (NYSE: NUS) has released its 2024 Social Impact and Sustainability Report, highlighting significant achievements in global giving and environmental sustainability. The report showcases the Nu Skin Force for Good Foundation's work, which has facilitated over 32,000 heart surgeries for children and contributed to the donation of more than 850 million meals through its Nourish the Children initiative. Additionally, the company made strides in reducing plastic waste, utilizing recycled materials, and achieving sustainable palm oil sourcing for its products.
Nu Skin Enterprises (NYSE:NUS) Stock Price Passes Above Two Hundred Day Moving Average - Should You Sell?
Nu Skin Enterprises (NYSE:NUS) stock recently traded above its 200-day moving average of $10.09, reaching $10.68. Analysts maintain a "Hold" rating with a consensus price target of $7.00, suggesting limited upside. The company reported better-than-expected Q3 EPS of $0.34 and announced a quarterly dividend of $0.06.
Nu Skin Unveils Prysm iO™: An Evolution in Intelligent Nutritional Wellness
Nu Skin Enterprises Inc. has launched Prysm iO™, an intelligent nutritional wellness platform designed to provide personalized insights into health by tracking carotenoid levels. This AI-powered device offers a non-invasive finger-scan to measure antioxidant health in under 15 seconds, supplementing a user's diet, fitness, and lifestyle choices. The platform is supported by over 20 years of research and integrates with Nu Skin's wellness ecosystem, with availability expanding to the public throughout 2026.
With 75% ownership, Nu Skin Enterprises, Inc. (NYSE:NUS) boasts of strong institutional backing
Institutional investors own 75% of Nu Skin Enterprises, Inc. (NYSE:NUS), indicating their significant influence on the company's share price and a vote of confidence in its future. The top 16 shareholders collectively hold 51% of the business, with The Vanguard Group and BlackRock being the largest, each owning 8.6%. Insiders also hold a small but significant stake, while the general public owns 23% of the company.
Walleye Capital LLC Lowers Stock Position in Nu Skin Enterprises, Inc. $NUS
Walleye Capital LLC significantly reduced its stake in Nu Skin Enterprises, Inc. (NYSE:NUS) by 52.4% during the second quarter, selling 175,435 shares and now owning 159,478 shares. Despite this, institutional investors collectively hold approximately 82.84% of the stock. Nu Skin exceeded EPS expectations for the recent quarter, forecasting FY2025 EPS between $1.25 and $1.35, and declared a quarterly dividend of $0.06.
Segall Bryant & Hamill LLC Invests $1.58 Million in Nu Skin Enterprises, Inc. $NUS
Segall Bryant & Hamill LLC has initiated a new position in Nu Skin Enterprises (NYSE:NUS), purchasing 198,006 shares valued at approximately $1.58 million during the second quarter. This investment gives the firm a 0.40% stake in the company. Nu Skin reported beating EPS expectations but missed on revenue, and announced a quarterly dividend of $0.06 per share.
Nu Skin Enterprises, Inc. (NYSE:NUS) Stock Goes Ex-Dividend In Just Four Days
Nu Skin Enterprises (NYSE:NUS) is set to trade ex-dividend in four days, with the ex-dividend date being November 28th and payment on December 10th. The company offers a 2.4% trailing yield, paying out US$0.24 per share annually, and its dividend is well-covered by both profits (11% payout ratio) and free cash flow (22% payout ratio). Despite this, the company has seen declining earnings per share (6.4% annually over five years) and a 10-year dividend payment decrease of 16% per year.
Nu Skin Enterprises Reports Third Quarter Earnings
Nu Skin Enterprises Inc. (NYSE: NUS) announced third quarter revenue of $364.2 million and EPS of $0.34, within its guidance. The company is preparing for the limited introduction of its Prysm iO intelligent wellness platform and a pre-market opening in India in the fourth quarter, aiming to stimulate growth and expand its global presence. Nu Skin's CEO, Ryan Napierski, highlighted strong double-digit growth in Latin America and positive sequential trends in several segments, emphasizing operational efficiency and upcoming strategic initiatives.
35,105 Shares in Nu Skin Enterprises, Inc. $NUS Purchased by Los Angeles Capital Management LLC
Los Angeles Capital Management LLC has acquired 35,105 shares of Nu Skin Enterprises, Inc. (NYSE:NUS), valued at approximately $280,000, representing a new stake of 0.07% ownership in the company. This comes amidst recent insider selling, with executives and directors offloading shares totaling over $700,000 in the last 90 days. Despite insider selling, Nu Skin recently exceeded Q3 earnings estimates and announced a quarterly dividend, while institutional investors now own 82.84% of the stock.
Earnings call transcript: Nu Skin Q3 2025 beats EPS expectations
Nu Skin Enterprises Inc. exceeded Q3 2025 EPS expectations with 34 cents against a 29-cent forecast, though revenue slightly missed targets at $364.2 million. The company's stock fell 2.16% in aftermarket trading, but analysis suggests it remains undervalued. Strategic initiatives include the launch of the Prism IO platform and expansion into the Indian market, expected to drive future growth.
Nu Skin Enterprises Reports Steady Q3 Earnings Amid Strategic Expansion
Nu Skin Enterprises (NUS) reported steady Q3 2025 earnings, aligning with guidance despite a 15.3% revenue decline to $364.2 million. The company's earnings per share doubled to $0.34, maintaining a strong gross margin of 70.5%. Strategic initiatives like the upcoming Prysm iO platform launch and expansion into India are expected to drive future growth, with full-year revenue projected between $1.48 to $1.51 billion.
The five-year shareholder returns and company earnings persist lower as Nu Skin Enterprises (NYSE:NUS) stock falls a further 15% in past week
Nu Skin Enterprises (NYSE:NUS) has seen its stock price drop by 82% over the last five years, with a further 19% decline in the past month, despite becoming profitable within this period. The company's revenue has also decreased by 12% annually over the last five years, suggesting long-term growth challenges. While the total shareholder return (TSR) including dividends (-79%) was slightly better than the share price return, recent performance shows a 43% TSR in the last twelve months, potentially indicating an inflection point.
Nu Skin Reports Q3 2025 Financial Results
Nu Skin Enterprises Inc. announced its financial results for Q3 2025, with revenue of $364.2 million, a 15.3% decline year-over-year, but in line with guidance. The company anticipates renewed growth with the upcoming launch of its Prysm iO intelligent wellness platform and expansion into India in late 2026. Gross margin remained stable at 70.5%, and earnings per share were at the high end of their guidance range, demonstrating "disciplined execution and operational efficiency."
Nu Skin (NYSE: NUS) declares $0.06 dividend payable Dec. 10 to shareholders
Nu Skin Enterprises Inc. (NYSE: NUS) announced that its board of directors has declared a quarterly cash dividend of $0.06 per share. This dividend will be paid on December 10, 2025, to shareholders of record as of November 28, 2025. The company specializes in intelligent beauty and wellness products, operating in nearly 50 markets worldwide.
Nu Skin Enterprises to Announce Third Quarter 2025 Financial Results - MarketScreener
Nu Skin Enterprises, Inc. (NYSE: NUS) announced that it will release its third-quarter 2025 financial results after market close on Thursday, November 6th. The management team will host a conference call on the same day at 5 p.m. ET to discuss results and upcoming business initiatives, with a webcast available on their investor relations page.
Wall Street Zen Upgrades Nu Skin Enterprises (NYSE:NUS) to "Strong-Buy" - MarketBeat
Nu Skin Enterprises (NYSE:NUS) has been upgraded from a "buy" to a "strong-buy" rating by Wall Street Zen analysts. Despite this upgrade, the stock trades down 6.6%, and insider Laura Nathanson sold 6,489 shares. The company reported better-than-expected earnings for the last quarter and expects FY 2025 EPS between $1.15 and $1.35.
Strength Seen in Nu Skin (NUS): Can Its 6.2% Jump Turn into More Strength?
Nu Skin Enterprises (NUS) saw its shares jump 6.2% on strong volume, driven by strategic execution, innovation, and international expansion, including the upcoming AI-powered Prysm iO device. Despite this momentum, the company's Q3 earnings per share are projected to rise significantly year-over-year, while revenues are expected to decline. Investors should monitor earnings estimate revisions as the stock currently holds a Zacks Rank #3 (Hold), indicating that continued strength relies on these revisions.
Stonegate Capital Partners Initiates Coverage on NU Skin Enterprises Inc. (NUS)
Stonegate Capital Partners has initiated coverage on NU Skin Enterprises Inc. (NUS), reporting strong Q2 results where adjusted EPS of $0.43 significantly exceeded guidance. The company achieved a 103.5% year-over-year growth in adjusted net income and saw notable revenue increases in its Rhyz Manufacturing segment (17% y/y) and Latin America (107% y/y). These positive results are attributed to a focus on revenue growth and operational optimization, positioning NU Skin for continued strong performance in 2Q25.
NU SKIN ENTERPRISES Earnings Results: $NUS Reports Quarterly Earnings | NUS Stock News
NU SKIN ENTERPRISES (NUS) reported strong quarterly earnings, beating analyst estimates for both earnings per share and revenue. The company posted earnings of $0.43 per share against an estimated $0.25, and revenue of $386.14 million against an estimated $380.44 million. The article also details recent insider trading activity with 1 purchase and 3 sales, and significant hedge fund activity including additions and reductions in NUS stock.
Nu Skin Enterprises, Inc. (NYSE:NUS) is a favorite amongst institutional investors who own 75%
Institutional investors own 75% of Nu Skin Enterprises (NYSE:NUS), indicating strong confidence in the company, though this also implies potential risks if multiple parties seek to sell simultaneously. BlackRock is the largest shareholder with 9.2%, and while insiders hold a small stake, their recent selling activity is noted. The general public owns 23% of the company, giving them some influence.
Multi-Level Marketing (MLM) Market Size | CAGR of 5.4%.
The global Multi-Level Marketing (MLM) market is projected to reach USD 322.3 billion by 2034, growing from USD 190.5 billion in 2024 at a CAGR of 5.4%. This growth is fueled by increasing social media adoption for marketing, rising demand for work-from-home opportunities, and an expanding global middle class. The Asia-Pacific region currently dominates the market, holding a 60% share, with Health & Wellness and Single-Tier Marketing segments leading the product type and marketing type categories, respectively.
US Direct Selling Market Size, Share | CAGR of 5.6%
The US Direct Selling Market is projected to reach USD 70.5 billion by 2034, growing at a CAGR of 5.6% from 2025. Health & Wellness dominates the market, driven by demand for nutritional supplements and immunity boosters, while social media and personalized shopping experiences boost growth. Key trends include influencer-driven campaigns and a shift towards sustainable and subscription-based models.
Nu Skin Enterprises Reports First Quarter Revenue at High End of Guidance
Nu Skin Enterprises (NYSE: NUS) reported first-quarter revenue at the high end of its guidance and exceeded adjusted earnings forecasts. The company achieved year-over-year growth in Latin America and its Rhyz manufacturing segment, despite consumer caution in premium beauty markets due to inflation and tariffs. Nu Skin is focused on new product launches, including the upcoming Prysm iO intelligent wellness device, and preparing for expansion into India.
Nu Skin Can't Avoid Distributor Dispute In Wash. Court
The Washington Supreme Court has ruled that Nu Skin Enterprises Inc. cannot force product distributors to litigate claims of pyramid scheme violations in Utah, affirming that the case can proceed in Washington state court. This decision resolves a split among lower appellate courts regarding the venue for disputes against the multilevel marketing company. Essentially, Nu Skin failed in its attempt to avoid a distributor dispute in Washington.
Should You Investigate Nu Skin Enterprises, Inc. (NYSE:NUS) At US$7.34?
Nu Skin Enterprises (NYSE:NUS) appears undervalued according to Simply Wall St's valuation model, suggesting a potential buying opportunity despite its share price volatility. However, the company faces an extreme expected decline in top-line growth over the next couple of years, introducing uncertainty and higher risk for investors. While currently a bargain, potential investors should consider the risks associated with negative growth prospects before making a decision.
Later Acquires Mavely for $250 Million
Later has acquired Mavely for $250 million from Rhyz Inc., a subsidiary of Nu Skin Enterprises (NYSE: NUS). This acquisition aims to enhance Later's influencer marketing platform by integrating Mavely's technology and expertise, enabling marketers to achieve attributable outcomes and empowering creators to build sustainable businesses. Mavely’s co-founders, Evan Wray, Sean O’Brien, and Kevin Kenefick, will join Later’s leadership team to shape the company's future.
Nu Skin Sets New GUINNESS WORLD RECORDS™ Title for the Most People Packing Meal Kits in 24 Hours
Nu Skin Enterprises, Inc. achieved a new GUINNESS WORLD RECORDS™ title for the Most People Packing Meal Kits in 24 Hours, with 2,196 participants packing over 550,000 meals. This event celebrated the company's 40th anniversary and reinforced its commitment to being a "force for good" by supporting children in need throughout the United States. The initiative was a collaborative effort with several organizations, and the packed meals will be distributed by Convoy of Hope and the Utah Food Bank.
Nu Skin lays off more employees amid financial woes
Nu Skin, a Provo-based multi-level marketing and wellness company, has laid off more employees following poor third-quarter earnings and a significant drop in revenues. This workforce reduction is part of a previously announced plan to optimize growth and profitability and save the company $45-65 million in expenses by the end of 2024. The company expects lower-than-forecasted earnings of roughly $1.7 billion in 2024 due to ongoing pressures.
Nu Skin reaches $47 million agreement to settle pyramid scheme lawsuit
Nu Skin Enterprises Inc. has agreed to a $47 million settlement to resolve a class-action lawsuit. The lawsuit alleged the company and its executives failed to disclose an unlawful pyramid scheme within its Chinese subsidiary, violating multi-level marketing regulations. This settlement, which awaits court approval, is not expected to impact Nu Skin's income statement as insurers are anticipated to cover the payment.
Nu Skin Ranked the World’s #1 Company for Beauty and Wellness Device Systems
Nu Skin Enterprises Inc. (NYSE: NUS) has been recognized by Euromonitor International Ltd. as the world’s #1 company for beauty and wellness device systems for 2024. The company's portfolio of advanced, proprietary, and personalized device systems, including ageLOC LumiSpa iO, Nu Skin RenuSpa iO, and ageLOC WellSpa iO, offers effective at-home beauty and wellness solutions. Nu Skin's products are backed by 40 years of scientific research and are available in nearly 50 markets worldwide.
Nu Skin Releases 2023 Social Impact and Sustainability Report
Nu Skin has released its 2023 Social Impact and Sustainability Report, detailing its progress in environmental and social initiatives. The report highlights significant contributions through its Force for Good Foundation, including over $6.8 million donated globally, 30,000 heart surgeries financed since 1999, and the provision of 33 million meals in 2023. Nu Skin also made strides in sustainability by assessing all products for environmental impact, reducing plastic and paper waste, and opening a new green manufacturing facility.
Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?
This article examines Nu Skin Enterprises' debt levels, noting that while the company carries debt, its net debt to EBITDA and interest coverage ratios suggest a reasonable use of debt. However, concerns are raised about its significant liabilities compared to market capitalization. The piece concludes by suggesting that while debt management seems decent based on EBITDA, the company's overall balance sheet health makes it a risky investment, especially given the decrease in EBIT.
Nu Skin Opens Shanghai Facility
Nu Skin Enterprises has invested approximately $55 million to open a new manufacturing facility in Shanghai, China. This 440,000 square feet facility, located in the Fengxian District, incorporates Industry 4.0 standards and green building practices to boost production capacity and supply chain efficiency across China and other Asian markets. This move reinforces Nu Skin's two-decade commitment to China, aiming to establish the region as a central hub for research, development, and manufacturing.
The 10 Richest People in Utah
This article lists the top 10 wealthiest individuals in Utah, detailing their net worth and how they accumulated their fortunes. It highlights figures like Gail Miller, Mitt Romney, and Ryan Smith, showcasing various paths to wealth from business and politics to biotechnology and entrepreneurship. The list reveals a diverse group of individuals who have significantly contributed to Utah's economic landscape.
Company takes back job offer because woman has one hand, feds say. Now it’ll pay
Elwood Staffing Services has agreed to pay $77,500 to settle a lawsuit filed by the EEOC, which accused the company of disability discrimination. The lawsuit stemmed from Elwood Staffing rescinding a job offer to a woman with one hand, despite her passing a skills test with a perfect score. The federal agency stated the company violated the Americans with Disabilities Act by making assumptions about her abilities instead of providing reasonable accommodation.
Nu Skin sees soft second quarter as layoffs rumored within company
Nu Skin is bracing for a soft financial second quarter, attributed to COVID-related factors in China, conflict in Europe, and a global economic downturn. The company expects to release full second-quarter results and updated guidance after market close on Thursday. Rumors of layoffs are circulating within the global beauty and wellness company.
Infosys Collaborates with Nu Skin to Drive Social Commerce-led Transformation in the Beauty and Wellness Sector
Infosys has announced a collaboration with Nu Skin Enterprises to transform the beauty and wellness sector through social commerce-led initiatives. Nu Skin will utilize Infosys Equinox, a human-centric digital commerce platform, to enhance consumer and affiliate experiences. This partnership aims to scale Nu Skin's business with engaging, personalized, and innovative digital interactions across various touchpoints.
Nu Skin Accelerates Social Commerce Capabilities with the Acquisition of Mavely
Nu Skin Enterprises, Inc. announced the acquisition of Mavely, a social commerce platform designed to streamline customer acquisition and social selling. This acquisition is expected to empower Nu Skin brand affiliates by providing new social selling capabilities and digital tools, contributing to Nu Skin's growth in the rapidly expanding global social commerce market. Mavely will continue to operate as an independent entity under Rhyz, Inc., Nu Skin's strategic investment arm.
